Navigation Links
CORRECTION: Star Scientific Issues Statement Correcting the Underreporting of the "Flint" CRP Human Study Results
Date:10/26/2012

GLEN ALLEN, Va., Oct. 26, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) announced today that the press release issued 10/24/2012, titled "Star Scientific Announces Successful First Look at the "Flint" CRP Human Study and Provides Updated Report on ASAP Human Thyroid Study", incorrectly stated the interim results of the "Flint" CRP study.  In the release, the Company reported: "After one month of supplementation, CRP levels dropped in 26% of the subjects with diabetes, compared with a drop in CRP levels in 12% of the general trial population of subjects who did not have diabetes." These figures reflected an understatement of the decrease in CRP levels after anatabine supplementation.  The correct figures are as follows: 11 of 18 (61%) diabetic subjects on metformin had a CRP reduction, as did 31 of 81 (38%) subjects in the general trial population not taking metformin.  Overall, 42 of 99 (42%) subjects had a decrease in CRP after only one month with anatabine supplementation. 

The anatabine used in the clinical trial is made under the Company's patented process and is the main ingredient in its Anatabloc® product, which is sold in GNC stores nationwide.

(Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO )

Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results
'/>"/>

SOURCE Star Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Discovery of New "Youth Pill" Revealed At International Scientific Conference
2. Presentation of Possible "Fountain of Youth" Pill Creating "Celebrity" Atmosphere at San Antonio Scientific Conference
3. Unigene To Present at the 2012 Obesity Societys 30th Annual Scientific Meeting
4. Eaton Scientific Expands Investor Relations Strategy and Launches Important New Website Content
5. Boston Scientific to Acquire BridgePoint Medical, Inc.
6. Eaton Scientific Teams Up with Renowned Womens Sexual Health Expert Dr. Jennifer R. Berman, MD and Berman Sexual Health to Advance Tropine 3 Trials and Marketing
7. Eaton Scientific Systems, Ltd. completes its Study Protocol for its Planned Clinical Trial of its Patent Pending Non-Hormonal Treatment of Hot Flashes.
8. Boston Scientific to Participate in the 2012 Morgan Stanley Global Healthcare Conference
9. Islet Sciences Appoints Dr. Kevan Herold and Dr. Morton Printz to Scientific Advisory Board
10. Eaton Scientific Enters Agreement with RoxSan Pharmacy to Provide Tropine 3 for its upcoming Clinical Trial Participants
11. Eaton Scientific Discusses Positive Anecdotal Feedback from Pharmacist Compounding Homatropine for Doctors Treating Patients Experiencing Hot Flash Symptoms in the Beverley Hills and Los Angeles Area.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Cryoport, Inc. (OTCBB: CYRX) today announced financial results for ... Recent Operating Highlights , Achieved 92% ... period ended June 30, 2014 compared to the prior ... expand Cryoport,s global reach using the ,powered by Cryoport ... an immunotherapy and vaccine development services company, to support ...
(Date:7/31/2014)... 31, 2014 Orexigen® Therapeutics, Inc. (Nasdaq: ... second quarter 2014, on Thursday, August 7, 2014 before ... live webcast and conference call at 8:00 a.m. Eastern ... will host the call and webcast to discuss financial ... be accessed by calling (800) 708-4540 (domestic) or (847) ...
(Date:7/31/2014)... N.J. , July 31, 2014  Celsion Corporation ... Company will host a conference call to discuss its ... on Thursday, August 7, 2014. To participate in the ... America ) or 1-785-830-1924 (International/Toll) and ask for ... Code: 8283269) to register ten minutes before the call ...
Breaking Medicine Technology:Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Celsion Corporation to Hold Second Quarter 2014 Financial Results 2
... Clinic,s Top 10 Medical Innovations for 2010 list features a ... developed to treat everything from deafness and Parkinson,s disease to ... devices and therapies was selected by a panel of Cleveland ... Cleveland Clinic,s 2009 Medical Innovation Summit , which ...
... Medco Health Solutions, Inc. (NYSE: MHS ) is ... getting the most value out of their Medicare prescription drug ... different plan options - Choice , Access , ... access to a vast array of medications, pharmacy locations, and ...
Cached Medicine Technology:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 2Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 3Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 4Medco's 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 2Medco's 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 3Medco's 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 4
(Date:7/31/2014)... of adults with ADHD improve when their ADHD ... College of Medicine researchers., At least 25 percent ... a parent with ADHD. , "Parents with ADHD ... parenting techniques, including inconsistent disciplinary practices, making ineffectual ... Waxmonsky, associate professor of psychiatry. "Having a parent ...
(Date:7/31/2014)... 2014 Jacuzzi Luxury Bath, ... has launched a new and improved website to meet ... The Jacuzzi Luxury Bath website has been redesigned to ... and quality represented by the company’s products. The design ... and inspirational bathroom applications. “The site reflects our Jacuzzi® ...
(Date:7/31/2014)... The “Nucleic Acid Isolation and Purification ... bead based), Consumables & Instruments, by Application (Plasmid ... users - Global Forecasts to 2018” provides a ... opportunities, current market trends, and strategies impacting the ... with the estimates and forecasts of the revenue ...
(Date:7/31/2014)... Long associated with enabling the proliferation of ... by Heat-Shock Factor 1 (HSF1) can also turn ... support malignant progression and metastasis. , The finding, ... the journal Cell , lends new insights ... diagnosis, prognosis, and management of cancer patients. ...
(Date:7/31/2014)... According to a new market report ... Market - Global Forecast, Market Share, Size, Growth and ... fixation devices market is estimated at USD 6.1 billion ... CAGR of 7.2% from 2014 to 2019, to reach ... Globally, the orthopedic trauma fixation devices market is witnessing ...
Breaking Medicine News(10 mins):Health News:Parenting skills improve in ADHD parents with medication 2Health News:Jacuzzi Luxury Bath Launches New and Improved Website 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Master HSF supports reprogramming of normal cells to enable tumor growth and metastasi 2Health News:Master HSF supports reprogramming of normal cells to enable tumor growth and metastasi 3Health News:Orthopedic Trauma Fixation Devices Market: Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020 2Health News:Orthopedic Trauma Fixation Devices Market: Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020 3
... Allows Pharmaceutical Brand Managers to Build Patient-Flow Models ... Decision Resources, one of the world,s leading ... healthcare issues, finds that use of Novartis, Diovan ... Cozaar is influenced by physician perception that the ...
... Pharmaceutical Research and Manufacturers of America (PhRMA) President and ... a new healthcare reform coalition:"PhRMA echoes the sentiment shared ... is critical for all Americans to have access to ... central goal in mind, we are working with a ...
... stroke specialists, especially in rural or other underserved areas; ... a "mini" or "warning" stroke, should be treated with ... two separate scientific statements and a policy statement published ... Association . , Telemedicine Statement Highlights: , ...
... May 11 David Cornfield, MD, the chief ... Lucile Packard Children,s Hospital at Stanford, has been ... (SPR).(Photo: http://www.newscom.com/cgi-bin/prnh/20090511/SF14213 )Beginning this month, Cornfield ... pediatricians for a one-year term. "It,s a great ...
... WASHINGTON, May 11 President Obama and U.S. Senate ... protection laws as suggested by health insurers last week, ... said Consumer Watchdog in a letter to the president ... every state over the last 10 years were made ...
... run on behalf of 1.275 million Americans living with spinal ... Dana Reeve Foundation today announced Matthew Reeve, son of Christopher ... Reeve Foundation, will run the 2009 ING New York City ... inspired to compete on behalf of the 1.275 million Americans ...
Cached Medicine News:Health News:More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro 2Health News:More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro 3Health News:PhRMA Statement on Healthcare Reform Coalition 2Health News:PhRMA Statement on Healthcare Reform Coalition 3Health News:PhRMA Statement on Healthcare Reform Coalition 4Health News:Videoconferencing can increase patient access to stroke specialists 2Health News:Videoconferencing can increase patient access to stroke specialists 3Health News:Packard/Stanford Physician to Lead Society for Pediatric Research 2Health News:President Obama, Sens. Kennedy & Baucus: Don't Buy Insurer 'Compromise' for Bush-era Plan to Gut State Consumer Protection Laws 2Health News:President Obama, Sens. Kennedy & Baucus: Don't Buy Insurer 'Compromise' for Bush-era Plan to Gut State Consumer Protection Laws 3Health News:Matthew Reeve to Run 2009 ING New York City Marathon for Team Reeve 2Health News:Matthew Reeve to Run 2009 ING New York City Marathon for Team Reeve 3
... Package is a solid solution ... The package includes the Vibratome ... mounting blocks, v-block adapter, specimen ... rotating stage assembly for ease ...
... Professional Package is the best ... laboratory. The package includes the ... additional mounting blocks, v-block adapter, ... a sapphire blade for the ...
... Vibratome 3000 Plus Sectioning System provides a ... animal, or plant tissues. The 3000 ... sectioning without freezing or embedding. The ... the destruction of enzyme activities, and other ...
... System provides a versatile means of sectioning ... The 1500 employs a vibrating blade ... embedding. The creation of artifacts, the ... activities, and other deleterious effect inherent in ...
Medicine Products: